Review article · 2024

An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)

Christopher M. Marshall, John G. Federice, Chloe N. Bell, Philip B. Cox, Jón T. Njardarson

Journal of Medicinal Chemistry, 67(14), 11622–11655 · Published 12 July 2024 · DOI 10.1021/acs.jmedchem.4c01122

View at the publisherCite this paper

In brief

“An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)” is a 2024 review article by Christopher M. Marshall and 4 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 1,191 citations as of 15 November 2026, which puts it in the top 1% of works published in 2024 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
1,191
Most cited in
2026 (645)
Field-weighted impact
30.95
References
159
Authors
5

Abstract

This Perspective is a continuation of our analysis of U.S. FDA-approved small-molecule drugs (1938–2012) containing nitrogen heterocycles. In this study we report drug structure and property analyses of 321 unique new small-molecule drugs approved from January 2013 to December 2023 as well as information about frequency of important heteroatoms such as sulfur and fluorine and… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Marshall, C. M., Federice, J. G., Bell, C. N., Cox, P. B., & Njardarson, J. T. (2024). An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023). Journal of Medicinal Chemistry, 67(14), 11622–11655. https://doi.org/10.1021/acs.jmedchem.4c01122

MLA 9

Marshall, Christopher M., et al. “An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023).” Journal of Medicinal Chemistry, vol. 67, no. 14, 2024, pp. 11622–11655. https://doi.org/10.1021/acs.jmedchem.4c01122.

Chicago

Marshall, Christopher M., John G. Federice, Chloe N. Bell, Philip B. Cox, and Jón T. Njardarson. 2024. “An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023).” Journal of Medicinal Chemistry 67 (14): 11622–11655. https://doi.org/10.1021/acs.jmedchem.4c01122.

Harvard

Marshall, C. M. et al. (2024) ‘An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)’, Journal of Medicinal Chemistry, 67(14), pp. 11622–11655. doi:10.1021/acs.jmedchem.4c01122.

IEEE

C. M. Marshall, J. G. Federice, C. N. Bell, P. B. Cox, and J. T. Njardarson, “An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023),” Journal of Medicinal Chemistry, vol. 67, no. 14, pp. 11622–11655, 2024, doi: 10.1021/acs.jmedchem.4c01122.

BibTeX

@article{marshall2024update,
  title     = {{An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)}},
  author    = {Marshall, Christopher M. and Federice, John G. and Bell, Chloe N. and Cox, Philip B. and Njardarson, Jón T.},
  journal   = {Journal of Medicinal Chemistry},
  year      = {2024},
  volume    = {67},
  number    = {14},
  pages     = {11622--11655},
  doi       = {10.1021/acs.jmedchem.4c01122},
  url       = {https://doi.org/10.1021/acs.jmedchem.4c01122}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20246767
2025479479
2026645645

Its field-weighted citation impact is 30.95: it has been cited 30.95 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • nitrogen heterocycles
  • pyridine
  • piperidine
  • pyrimidines
  • pyrazole derivatives
  • morpholine
  • fused nitrogen heterocycles
  • fluorinated drugs

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Marshall, C. M., Federice, J. G., Bell, C. N., Cox, P. B., & Njardarson, J. T. (2024). An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023). Journal of Medicinal Chemistry, 67(14), 11622–11655. https://doi.org/10.1021/acs.jmedchem.4c01122

How many times has this paper been cited?

1,191 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Christopher M. Marshall, John G. Federice, Chloe N. Bell, Philip B. Cox, Jón T. Njardarson.

What is the DOI of this paper?

10.1021/acs.jmedchem.4c01122. The permanent link is https://doi.org/10.1021/acs.jmedchem.4c01122.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.